| __timestamp | Johnson & Johnson | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22746000000 | 176081000 |
| Thursday, January 1, 2015 | 21536000000 | 157939000 |
| Friday, January 1, 2016 | 21685000000 | 164073000 |
| Sunday, January 1, 2017 | 25354000000 | 169243000 |
| Monday, January 1, 2018 | 27091000000 | 168489000 |
| Tuesday, January 1, 2019 | 27556000000 | 172526000 |
| Wednesday, January 1, 2020 | 28427000000 | 200649000 |
| Friday, January 1, 2021 | 23402000000 | 237513000 |
| Saturday, January 1, 2022 | 24596000000 | 353358000 |
| Sunday, January 1, 2023 | 26553000000 | 586886000 |
| Monday, January 1, 2024 | 27471000000 |
Unleashing the power of data
In the ever-evolving landscape of healthcare, cost efficiency remains a pivotal factor for success. Over the past decade, Johnson & Johnson and Lantheus Holdings, Inc. have showcased contrasting trajectories in their cost of revenue. From 2014 to 2023, Johnson & Johnson's cost of revenue has seen a steady increase, peaking at approximately 26.6 billion in 2023, marking a 17% rise from 2014. In contrast, Lantheus Holdings, Inc. has experienced a more dramatic surge, with its cost of revenue skyrocketing by over 230% during the same period, reaching nearly 587 million in 2023. This stark difference highlights the diverse strategies and market dynamics faced by these two industry players. As Johnson & Johnson continues to leverage its scale, Lantheus Holdings, Inc. is rapidly expanding its footprint, reflecting the dynamic nature of the healthcare sector.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Gilead Sciences, Inc.
Cost of Revenue Comparison: Johnson & Johnson vs Regeneron Pharmaceuticals, Inc.
Johnson & Johnson vs Viatris Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Johnson & Johnson and Cytokinetics, Incorporated's Expenses
Johnson & Johnson vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Johnson & Johnson vs Galapagos NV: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Zoetis Inc. vs Lantheus Holdings, Inc.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Lantheus Holdings, Inc.
Lantheus Holdings, Inc. vs Perrigo Company plc: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs Galapagos NV
Lantheus Holdings, Inc. vs Evotec SE: Efficiency in Cost of Revenue Explored